Kennedy Capital Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $21.9M | Sell |
1,009,461
-51,862
| -5% | -$1.13M | 0.52% | 30 |
|
2025
Q1 | $25.7M | Buy |
1,061,323
+43,657
| +4% | +$1.06M | 0.61% | 18 |
|
2024
Q4 | $21.2M | Sell |
1,017,666
-23,750
| -2% | -$496K | 0.47% | 30 |
|
2024
Q3 | $20.7M | Sell |
1,041,416
-234,888
| -18% | -$4.67M | 0.46% | 32 |
|
2024
Q2 | $19.8M | Buy |
1,276,304
+214,600
| +20% | +$3.32M | 0.42% | 42 |
|
2024
Q1 | $16.9M | Buy |
1,061,704
+533,802
| +101% | +$8.51M | 0.35% | 70 |
|
2023
Q4 | $8.87M | Sell |
527,902
-108,464
| -17% | -$1.82M | 0.19% | 197 |
|
2023
Q3 | $7.44M | Buy |
636,366
+333,562
| +110% | +$3.9M | 0.18% | 206 |
|
2023
Q2 | $4.07M | Buy |
+302,804
| New | +$4.07M | 0.09% | 337 |
|
2019
Q2 | – | Sell |
-999,787
| Closed | -$5.1M | – | 696 |
|
2019
Q1 | $5.1M | Buy |
+999,787
| New | +$5.1M | 0.12% | 323 |
|
2018
Q4 | – | Sell |
-1,042,645
| Closed | -$3.94M | – | 696 |
|
2018
Q3 | $3.94M | Sell |
1,042,645
-11,226
| -1% | -$42.4K | 0.07% | 470 |
|
2018
Q2 | $3.29M | Buy |
1,053,871
+237,300
| +29% | +$740K | 0.06% | 521 |
|
2018
Q1 | $1.95M | Sell |
816,571
-74,603
| -8% | -$178K | 0.04% | 605 |
|
2017
Q4 | $3.48M | Sell |
891,174
-9,444
| -1% | -$36.9K | 0.06% | 529 |
|
2017
Q3 | $2.27M | Sell |
900,618
-17,820
| -2% | -$44.9K | 0.04% | 594 |
|
2017
Q2 | $2.54M | Buy |
918,438
+687,938
| +298% | +$1.9M | 0.05% | 553 |
|
2017
Q1 | $449K | Sell |
230,500
-2,671
| -1% | -$5.2K | 0.01% | 697 |
|
2016
Q4 | $245K | Sell |
233,171
-10,065
| -4% | -$10.6K | ﹤0.01% | 703 |
|
2016
Q3 | $265K | Sell |
243,236
-4,475
| -2% | -$4.88K | 0.01% | 696 |
|
2016
Q2 | $176K | Buy |
247,711
+3,259
| +1% | +$2.32K | ﹤0.01% | 696 |
|
2016
Q1 | $286K | Sell |
244,452
-3,765
| -2% | -$4.41K | 0.01% | 711 |
|
2015
Q4 | $608K | Sell |
248,217
-854
| -0.3% | -$2.09K | 0.01% | 690 |
|
2015
Q3 | $747K | Buy |
+249,071
| New | +$747K | 0.02% | 671 |
|